CME

CME commands a 2.5x revenue advantage, but Morningstar's unbroken eight-quarter growth streak tells a different story about momentum.

CME Group has delivered a strong share price run over the past few years, helped by heavy trading volumes and expansion across asset classes.

CME Group is back in focus after the fair value estimate in a recent model moved from US$292 to US$316, which feeds into higher price targets in the US$300 to US$360 range.

CME Group (CME) is back in focus after its Brazilian real futures set a new daily volume record, while a recent analyst rating upgrade highlighted improving earnings expectations and a shift in investor sentiment.

CME (CME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CME boasts a 62% net margin and minimal debt, while Mastercard captures 16% revenue growth with $16.4B in free cash flow.

CME Group (NasdaqGS:CME) plans to introduce new European dairy futures and options in collaboration with the European Energy Exchange.

Coinbase's revenue has fallen nearly 50% over two years while CME has held steady—a divergence that raises questions about their competitive positioning.

CME Group’s (NASDAQ: $CME) crypto derivatives trading volume reached $469.5 billion in notional value during ...

Financial exchanges CME stock, Cboe and ICE, along with Marex, Nasdaq and Tradeweb Markets, are benefiting from rotation out of AI stocks.

CME Group came into this Q3 2026 earnings print with its stock already on a strong run, and buyers then pushed it another 3.6% higher intraday to about US$306.